SCHEMBL1324760

SCHEMBL1324760

CN1CCN(Cc2ccc(NC(=O)c3coc4cc(Oc5ccnc(N)n5)ccc34)cc2C(F)(F)F)CC1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.72
CDK2 P24941 1/20 0.72
CDK8 P49336 1/20 0.72
KDR P35968 3/20 0.60
SRC P12931 5/20 0.53
FLT1 P17948 2/20 0.52
FLT4 P35916 2/20 0.52
ABL1 P00519 4/20 0.52
KIT P10721 6/20 0.50
EGFR P00533 1/20 0.49
BRAF P15056 1/20 0.49
RET P07949 3/20 0.48
PDGFRB P09619 1/20 0.47
MAP3K7 O43318 1/20 0.47
MAP4K2 Q12851 1/20 0.47
MAPK14 Q16539 1/20 0.47
MAP3K20 Q9NYL2 1/20 0.47
FGFR1 P11362 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1325318 0.91 CDK1 (0.59) CDK1CDK2CDK8KDRSRC
SCHEMBL2437488 0.88 KDR (0.78) CDK1CDK2CDK8KDRSRC
SCHEMBL1324080 0.86 CDK1 (0.72) CDK1CDK2CDK8KDRSRC
SCHEMBL29678277 0.84 CDK2 (1.00) CDK1CDK2CDK8KDRSRC
SCHEMBL3676641 0.84 CDK2 (1.00) CDK1CDK2CDK8KDRSRC
SCHEMBL1325272 0.84 KDR (0.61) CDK1CDK2CDK8KDRFLT1
SCHEMBL1324041 0.84 CDK1 (0.72) CDK1CDK2CDK8KDRSRC
SCHEMBL1324954 0.83 KDR (0.73) CDK1CDK2CDK8KDRFLT1
SCHEMBL1325191 0.82 CDK1 (0.72) CDK1CDK2CDK8KDRSRC
SCHEMBL2436659 0.80 CDK2 (0.72) CDK1CDK2CDK8KDRSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058276-B2 Heterobicyclic carboxamides as inhibitors for kinases NOVARTIS AG (CH) 2011-11-15 US disclosed
WO-2008009487-A1 HETEROBICYCLIC CARBOXAMIDES AS INHIBITORS FOR KINASES NOVARTIS AG (CH) 2008-01-24 WO disclosed